Results 11 to 20 of about 1,183,167 (309)

Noninvasively Assessed Portal Hypertension Grade Predicts Post-Hepatectomy Liver Failure in Patients With HepatocellCarcinoma: A Multicenter Study

Frontiers in Oncology, 2022
PurposeTo determine the predictive value of portal hypertension (PH) for the development of post-hepatectomy liver failure (PHLF) in patients with hepatocellular carcinoma (HCC).Patients and methodsThis study enrolled a total of 659 patients with HCC ...
Jitao Wang, Jitao Wang, Zhanguo Zhang, Dong Shang, Jinlong Li, Chengyu Liu, Peng Yu, Mingguang Wang, Dengxiang Liu, Hongrui Miao, Shuang Li, Biao Zhang, Anliang Huang, Yewei Zhang, Shubo Chen, Xiaolong Qi   +15 more
doaj   +1 more source

PATHOPHYSIOLOGY OF PORTAL HYPERTENSION [PDF]

Clinics in Liver Disease, 1964
Portal hypertension is a major complication of liver disease that results from a variety of pathologic conditions that increase the resistance to the portal blood flow into the liver. As portal hypertension develops, the formation of collateral vessels and arterial vasodilation progresses, which results in increased blood flow to the portal circulation.
Roberto J. Groszmann, Tarun K. Gupta, Lisa Chen   +2 more
openaire   +6 more sources

Portal Hypertension

Current Opinion in Gastroenterology, 2009
Portal hypertension is the most common complication of cirrhosis accounting for significant morbidity and mortality mainly because of variceal hemorrhage, ascites, bacterial infections, hepatic encephalopathy, and hepatorenal syndrome. Advances in the diagnosis and management of portal hypertension over the last year are reviewed.The measurement of the
Andrés, Cárdenas, Pere, Ginès
openaire   +3 more sources

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension

Gut, 2020
These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG) under
D. Tripathi, A. Stanley, P. Hayes, S. Travis, M. Armstrong, E. Tsochatzis, I. Rowe, N. Roslund, H. Ireland, Mandy Lomax, Joanne A Leithead, H. Mehrzad, R. Aspinall, J. Mcdonagh, D. Patch   +14 more
semanticscholar   +1 more source

Hepatic venous pressure gradient-guided laparoscopic splenectomy and pericardial devascularisation versus endoscopic therapy for secondary prophylaxis for variceal rebleeding in portal hypertension (CHESS1803): study protocol of a multicenter randomised controlled trial in China

BMJ Open, 2020
Introduction Gastro-oesophageal variceal bleeding is one of the most common and severe complications with high mortality in cirrhotic patients who developed portal hypertension.
Xiaolong Qi, Ruoyang Shao, Zhiwei Li, Jitao Wang, Ruizhao Qi, Qingbo Liu, Weijie Zhang, Xiaorong Mao, Xiaojing Song, Yanna Liu, Chuan Liu, Changzeng Zuo, Weidong Wang   +12 more
doaj   +1 more source

Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score

JHEP Reports, 2022
Background & Aims: Acute-on-chronic liver failure (ACLF) is a syndrome associated with organ failure and high short-term mortality. Recently, the role of surgery as a precipitating event for ACLF has been characterised.
Johannes Chang, Pauline Höfer, Nina Böhling, Philipp Lingohr, Steffen Manekeller, Jörg C. Kalff, Jonas Dohmen, Dominik J. Kaczmarek, Christian Jansen, Carsten Meyer, Christian P. Strassburg, Jonel Trebicka, Michael Praktiknjo   +12 more
doaj   +1 more source

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.

American Journal of Gastroenterology, 2020
INTRODUCTION We aimed to explore the prevalence of portal hypertension in the most common etiologies of patients with compensated advanced chronic liver disease (cACLD) and develop classification rules, based on liver stiffness measurement (LSM), that ...
M. Pons, S. Augustin, B. Scheiner, M. Guillaume, M. Rosselli, S. Rodrigues, H. Stefanescu, M. Ma, M. Mandorfer, Mayka Mergeay-Fabre, B. Procopeț, P. Schwabl, A. Ferlitsch, G. Semmler, A. Berzigotti, E. Tsochatzis, C. Bureau, T. Reiberger, J. Bosch, J. Abraldes, J. Genescà   +20 more
semanticscholar   +1 more source

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics

World Journal of Gastroenterology, 2020
Portal hypertension and bleeding from gastroesophageal varices is the major cause of morbidity and mortality in patients with cirrhosis. Portal hypertension is initiated by increased intrahepatic vascular resistance and a hyperdynamic circulatory state ...
L. Gunarathne, Harinda Rajapaksha, N. Shackel, P. Angus, C. Herath   +4 more
semanticscholar   +1 more source

NAFLD‐related hepatocellular carcinoma: The growing challenge

Hepatology, EarlyView., 2022
Risk and protective factors for NAFLD‐related hepatocellular carcinoma Abstract Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the burden of disease exponentially.
Pir Ahmad Shah, Rashmee Patil, Stephen A. Harrison   +2 more
wiley   +1 more source

The Presence of Ascites Affects the Predictive Value of HVPG on Early Rebleeding in Patients with Cirrhosis

Gastroenterology Research and Practice, 2020
Background and Aims. Gastroesophageal variceal bleeding is a serious complication of portal hypertension in cirrhotic patients and could be predicted by hepatic venous pressure gradient (HVPG).
Chuan Liu, Ruoyang Shao, Sining Wang, Guangchuan Wang, Lifen Wang, Mingyan Zhang, Yanna Liu, Mingkai Liang, Xiaoguo Li, Ning Kang, Jitao Wang, Dan Xu, Hua Mao, Chunqing Zhang, Xiaolong Qi   +14 more
doaj   +1 more source